2017 annual financial data
Sutro Biopharma 2017 Operating margin
Direct answer
Operating margin was -37.25%.
Operating income was -19.27M USD and net income was -19.69M USD.
Operating cash flow was -37.07M USD.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 51.74M USD
- Operating income
- -19.27M USD
- Net income
- -19.69M USD
- Operating cash flow
- -37.07M USD